Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Use of mogamulizumab for refractory Sezary syndrome in real clinical practice: report of three cases

Irene Navarro Navarro, Alejandro Ortiz Prieto,Mercedes Morillo Andujar,Fatima de la Cruz Vicente,Francisco Javier Capote Huelva,David Jimenez Gallo,Mario Linares Barrios,Julian Conejo-Mir Sanchez

EUROPEAN JOURNAL OF CANCER（2021）

Cited 0|Views7
No score
Abstract
Sézary syndrome (SS) is a cutaneous T cell lymphoma (CTLC) with poor prognosis which can present de novo or secondary to mycosis fungoides (MF). We report our experience treating patients with SS with mogamulizumab (n=3).
More
Translated text
Key words
Mogamulizumab, clinical practice, Sezary syndrome, cutaneous T cell lymphoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined